Broadcast

Visitation Alert

Back

ACO Information - Orlando Health Collaborative Care - Accountable Care Organization

ACO Name and Location

Orlando Health Collaborative Care
1414 Kuhl Ave. MP2
Orlando, Florida 32806 

ACO Primary Contact

Primary Contact Name

Robyn Bartek

Primary Contact Phone Number

321.843.8366

Primary Contact Email Address

[email protected]

Organizational Information

ACO participants:

ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

West Orange Physicians Group, LLC

N

Orlando Health, Inc.

N

Orlando Physicians Network, Inc

N

Orlando Health Physician Group, Inc.

N

South Lake Hospital, Inc.

N

Physician Associates, LLC

N

ACO governing body:

Member

Member's Voting Power

Membership Type

ACO Participant TIN Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

Senne

Jerry

Executive Director

1

ACO Participant Representative

Orlando Health

Spong

Bernadette

Chief Financial Officer, Orlando Health

1

ACO Participant Representative

Orlando Health

Vacant

Vacant

Vacant

1

ACO Participant Representative

Orlando Health

Walker

Erik

MD

1

ACO Participant Representative

Orlando Health Physician Associates

Kaplan

Benjamin

MD

1

ACO Participant Representative

Orlando Physicians Network

Jackson

Amy

MD

1

ACO Participant Representative

West Orange Physician Group

Soto

Martin

MD

1

ACO Participant Representative

Orlando Health Physician Associates

Desai

Sunil

MD

1

ACO Participant Representative

Orlando Health Physician Group, Inc. 

MacDiarmid

Malcolm

 

1

Medicare Beneficiary Representative

 

Key ACO clinical and administrative leadership:

Jerry Senne

ACO Executive

Martin Soto

Medical Director

Dave Huddleson

Compliance Officer

Benjamin Kaplan

Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name

Committee Leader Name and Position

Quality Improvement and Care Coordination

Benjamin Kaplan, MD, Chair

Finance and Operations

Erik Walker, MD, Chair

Compliance

David Huddleson, Chair

 

  

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2018, $3,099,021
    • Performance Year 2017, $0
    • Performance Year 2016, $0
  • First Agreement Period
    • Performance Year 2015, $2,696,226
    • Performance Year 2014, $2,421,969
    • Performance Year 2013, $1,469,180 

Shared Savings Distribution

  • Second Agreement Period
    • Performance Year 2018
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 40%
      • Proportion of distribution to ACO participants: 40%
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2015
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 40%
      • Proportion of distribution to ACO participants: 40%
    • Performance Year 2014
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 40%
      • Proportion of distribution to ACO participants: 40%
    • Performance Year 2013
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 40%
      • Proportion of distribution to ACO participants: 40% 

Quality Performance Results

2018 Quality Performance Results:

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

84.69

86.14

ACO-2

CAHPS: How Well Your Providers Communicate

92.56

93.93

ACO-3

CAHPS: Patients’ Rating of Provider

90.87

92.45

ACO-4

CAHPS: Access to Specialists

82.07

81.50

ACO-5

CAHPS: Health Promotion and Education

61.57

59.26

ACO-6

CAHPS: Shared Decision Making

59.15

61.94

ACO-7

CAHPS: Health Status/Functional Status

73.84

73.35

ACO-34

CAHPS: Stewardship of Patient Resources

24.16

26.26

ACO-8

Risk Standardized, All Condition Readmission

14.71

14.98

ACO-35

Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)

18.01

18.59

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

32.64

37.01

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

64.88

76.75

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

53.57

59.00

ACO-43

Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))

1.60

1.98

ACO-11

Use of Certified EHR Technology

100.00

98.20

ACO-12

Medication Reconciliation

87.76

85.91

ACO-13

Falls: Screening for Future Fall Risk

98.51

79.73

ACO-44

Imaging Studies for Low Back Pain

64.71

64.36

ACO-14

Preventive Care and Screening: Influenza Immunization

86.35

72.71

ACO-15

Pneumonia Vaccination Status for Older Adults

88.80

75.97

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up

92.07

76.83

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

86.67

72.81

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

75.50

66.74

ACO-19

Colorectal Cancer Screening

81.79

68.27

ACO-20

Breast Cancer Screening

77.30

71.96

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

85.91

81.47

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

10.41

15.51

ACO-41

Diabetes: Eye Exam

61.77

52.42

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

73.68

73.10

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

84.15

88.92

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. 

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

  • Yes, our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR 425.612.